Dual effect of Platelet Factor 4 on the activities of Factor Xa.
Platelet Factor 4 (PF4) prevents inhibition of blood coagulation proteases by heparin via formation of a putative enzyme-PF4 complex. To investigate the contribution of the latter, the activity of factor Xa (fXa) was determined in chromogenic assays measuring hydrolysis of a peptide substrate S2765 or cleavage of the macromolecular substrate prothrombin in the activating complex, prothrombinase. Upon preincubation with fXa and heparin, PF4 at about 250 nM decreased the k(cat) of S2765 hydrolysis about fivefold and that of prothrombin activation about 25-fold. In the presence of saturating fVa, inhibition of fXa by PF4 was abolished, while in the presence of limiting fVa, PF4 altered the interaction of fXa with fVa. Interestingly, high concentrations of PF4 restored fXa activity toward S2765 and prothrombin, indicating a dual effect of PF4 on fXa activities. These findings suggest that PF4 in the presence of heparin is an allosteric effector of the prothrombinase complex.
Fiore
Martine M
MM
University College London, Haemostasis Research Unit, Department of Haematology, 51, Chenies Mews, London WC1E 6HX, United Kingdom. m.fiore@ucl.ac.uk
Mackie
Ian J
IJ
D000494:Allosteric Regulation; D001777:Blood Coagulation; D015951:Factor Xa / Q000737:chemistry*; D006493:Heparin / Q000737:chemistry*; D006868:Hydrolysis; D009842:Oligopeptides / Q000737:chemistry; D010978:Platelet Factor 4 / Q000737:chemistry*
D009842:Oligopeptides; D010978:Platelet Factor 4; C015608:benzoyl-Ile-Glu-Gly-Arg-p-nitroanilide; D006493:Heparin; D015951:Factor Xa